In this study, we constructed a subcutaneous tumor model of pancreatic cancer and applied a combination of Decorin-carrying oncolytic adenoviruses and chemotherapy for <i>in vivo</i> and <i>in vitro</i> experiments. This evidence concerns the gene DCN and familial pancreatic carcinoma.